Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction

NCT01440517 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Subject Recruitment

Conditions

Diabetes Mellitus
Heart Failure

Interventions

DRUG: Tc99m-Maraciclatide

Sponsor

GE Healthcare